| APLT Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the APLT shares outstanding history going back to 6/14/2019:
Also see: APLT Market Cap History APLT YTD Return |
APLT Shares Outstanding History — Applied Therapeutics Share Count Over Time
As of 11/12/2025 Applied Therapeutics has 144.30 million APLT shares outstanding. Investors often track the APLT shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows APLT share count trends over time, with 27 historical shares outstanding datapoints presented, dating back to 6/14/2019.
| APLT Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
APLT Historical Shares Outstanding: +39.47% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| APLT Stock Price Chart |
| About Applied Therapeutics Inc |
| Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It is focused on developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need. Co.'s lead drug candidate, govorestat, is a novel central nervous system penetrant Aldose Reductase Inhibitor (ARI) for the treatment of central nervous system (CNS) rare metabolic diseases, including Galactosemia, Sorbitol Dehydrogenase (SORD) Deficiency, and PMM2-CDG. Co. is also developing AT-001, a novel potent ARI, for the treatment of Diabetic Cardiomyopathy (DbCM) a fatal fibrosis of the heart. We show 27 historical shares outstanding datapoints in our coverage of APLT's shares outstanding history. Understanding the changing numbers of APLT shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like APLT versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching APLT by allowing them to research APLT shares outstanding history as well as any other stock in our coverage universe. |
| APLT Current Stock Quote |
Quotes delayed 20 minutes  Free APLT Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| APLT Share Performance |
| Shares Outstanding Peers |
| Applied Therapeutics (APLT) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
APM Shares Outstanding History APR Shares Outstanding History APRE Shares Outstanding History APRI Shares Outstanding History APTX Shares Outstanding History APVO Shares Outstanding History APYX Shares Outstanding History AQST Shares Outstanding History AQXP Shares Outstanding History ARA Shares Outstanding History More Healthcare companies » |
APLT Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
